Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

News SummaryMost relevantAll newsSector newsTweets 

MCKESSON CORP : McKesson Board Turns Blind Eye to Shareholders

share with twitter share with LinkedIn share with facebook
share via e-mail
10/30/2009 | 06:55pm CEST

Teamster Proposal Seeking Investor Approval of 'Golden Coffins' Garnered 51 Percent of Votes Cast For or Against; Union Calls on Board to Stop Hiding Behind Technicalities and Follow Will of Investors

WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- In a quarterly report released this week McKesson Corporation (NYSE: MCK) said that a Teamsters General Fund shareholder proposal that was supported by 51.4 percent of the actual responding votes cast for or against was not approved at the company's annual meeting of shareholders on July 22, 2009.

The proposal, which sought shareholder approval of "golden coffin" agreements that provide payments or awards after a senior executive's death, did not reach the level required for approval because abstentions were counted as votes against in the final vote tally, explained the company.

"McKesson shareholders clearly support this common sense proposal, and the company should honor the shareholders' will and adopt it," said Teamsters General Secretary-Treasurer C. Thomas Keegel. "The Board of Directors needs to accede to the will of its investors and not allow a voting technicality to defend egregious pay packages that go directly against pay-for-performance."

According to McKesson's 2009 proxy statement, the heirs of CEO John H. Hammergren would receive posthumous benefits estimated at $25 million to $39 million in the event of his death. These benefits do not include the estimated $79.7 million that his heirs would receive under the Executive Benefit Retirement Plan.

"Mr. Hammergren took home $29 million in total realized pay last year alone and has ample opportunities to provide for his estate. We believe shareholders should have a say in whether they're saddled with payments made without receiving any services in return, and clearly our fellow McKesson shareholders agree," Keegel said.

In the final vote tally, 107,598,016 votes were cast for the Teamsters' proposal, 101,659,126 votes were cast against, 6,066,692 votes abstained, and there were 23,724,672 broker non-votes. Broker non-votes had no effect on the vote results.

Founded in 1903, the International Brotherhood of Teamsters represents 1.4 million hardworking men and women in the United States, Canada and Puerto Rico.

SOURCE International Brotherhood of Teamsters

share with twitter share with LinkedIn share with facebook
share via e-mail
06:24p MCKESSON : Sources Sought Notice - Anthihemphilic Recombinate IV Solution 2100 U..
05:09p MCKESSON : Flu Trends to Watch in 2017-2018
03/23 MCKESSON : $101,057 Federal Contract Awarded to McKesson
03/22 MCKESSON : Big Data Poses Big Headaches as Health Care Industry Adopts HIT Syste..
03/20 MCKESSON : Emerging Technologies Define Pharmacy of the Future
03/20 MCKESSON : The Business of Health Care March 2017
03/20 MCKESSON : KISQALI® (ribociclib) Approved for the Treatment of HR+/HER2- Advance..
03/17 MCKESSON : Research Reports Initiation on Services Stocks -- GNC Holdings, Cardi..
03/15 MCKESSON : The Business of Health Care February 2017
03/15 MCKESSON : How Health Care Providers Can Transition to Value-Based Care
More news
Sector news : Drug Retailers - NEC
03/08DJHealth Costs Get a Rethink -- WSJ
02/28 Valeant predicts tough 2017 with revenue to decline
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
More sector news : Drug Retailers - NEC
News from SeekingAlpha
03/23 THE THREAT AND RISK OF RISING INTERE : Separating Fact From Fiction
03/22 AMERISOURCEBERGEN : Fear Of Regulatory Changes Presents An Attractive Upside Pot..
03/21 RETIREES : How To Generate The Income You Need From A Dividend Portfolio
03/20 IMMUNE SYNAPSE : Beautiful Under The Microscope, Kiss Of Death For A Cancer Cell
03/08 VALUATION DASHBOARD : Healthcare - Update